Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityNo recent work listed

Xiangdong Cheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1470-2831; OpenAlex author ID A5100758431. Sources: ClinicalTrials.gov.

Their work

Papers
3 (first author 1, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: none · 2022: 1 paper, 1 trial

Papers 3

  1. Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis. Co-author DOI 10.1186/s12943-022-01538-4↗
  2. Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review. First author DOI 10.1186/s12964-019-0435-2↗
  3. Inflammatory and Senescent Phenotype of Pancreatic Stellate Cells Induced by Sqstm1 Downregulation Facilitates Pancreatic Cancer Progression. Co-author DOI 10.7150/ijbs.27825↗

Trials 1

  1. Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors Principal investigator NCT05441046↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiang‐Jiang Qin · 2 shared papers, 2019–2022 · strength 0.29
  2. Simin Qi · 1 shared paper, 2022 · strength 0.15
  3. Xiaoqing Guan · 1 shared paper, 2022 · strength 0.15
  4. Weidong Zhang · 1 shared paper, 2022 · strength 0.15
  5. Wenjuan Yin · 1 shared paper, 2022 · strength 0.15
  6. Weidong Zhang · 1 shared paper, 2019 · strength 0.14
  7. Wei Chen · 1 shared paper, 2019 · strength 0.10
  8. Chuxiao Shao · 1 shared paper, 2019 · strength 0.10
  9. Xiaoguang Wang · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.